Catalyst Wire Dossier Catalyst Wire Dossier

icodec

insulin icodec · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for icodec, covering 2026-06-03 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes [Phase 3]

See pricing